Description
Maraviroc is a potent and selective C-C chemokine receptor type 5 (CCR5) antagonist drug that is designed to act against HIV by interfering with the interaction between HIV and CCR5.
Maraviroc is a potent and selective C-C chemokine receptor type 5 (CCR5) antagonist drug that is designed to act against HIV by interfering with the interaction between HIV and CCR5.
Alternate Name/Synonyms: 4,4-difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-cyclohexanecarboxamide; UK427857; MVC
Appearance: White solid
Formulation: N/A
CAS Number: 376348-65-1
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₉H₄₁F₂N₅O
Molecular Weight: 513.67
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO (>30 mg/ml)
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A potent and selective C-C chemokine receptor type 5 (CCR5) antagonist
MDL Number: MFCD13188530
PubChem CID: 3002977
SMILES: CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C
InChi: InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1
InChi Key: GSNHKUDZZFZSJB-HLMSNRGBSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |